Pfizer bulk deals, insider trading and stake changes
NSE: PFIZERBSE: 500680Pharmaceuticals & BiotechnologySmall Cap
Share price at the NSE close on 29 Oct 2026. Previous close ₹3,734.40.
29 Oct: open ₹3,749.00, high ₹3,799.00, low ₹3,732.30
- Next results date: the board meets on 3 Nov 2026 to consider: financial results. The notice · Results calendar
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹17,200 Cr327th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 23.40
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 4.09
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 1.99%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 17.5%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 21.0%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.00
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 13,53757.2% delivered
Pfizer's insiders have 5 trade disclosures on record, the latest on 4 May 2020. Its promoter group made no purchase or sale on the market in the 12 months to 29 Oct 2026.
Pfizer insider trading
The company's own latest disclosure on record is from May 2020.Insider trading, all companies
Feb 2020
- Anil Gupta₹0.01 Cr25 sharesBought · Employees/Designated Employees · 20 Feb 2020 · disclosed 29 Apr · held 100 before, holds 125 after
- Anil Gupta₹0.04 Cr100 sharesBought · Employees/Designated Employees · 17 Feb 2020 · disclosed 29 Apr · holds 100 after
- Anil Gupta₹0.07 Cr150 sharesSold · Employees/Designated Employees · 12 Feb 2020 · disclosed 29 Apr · held 150 before
- Anil Gupta₹0.01 Cr25 sharesBought · Employees/Designated Employees · 4 Feb 2020 · disclosed 29 Apr · held 125 before, holds 150 after
- Anil Gupta₹0.05 Cr125 sharesBought · Employees/Designated Employees · 3 Feb 2020 · disclosed 29 Apr · holds 125 after
Trades by the company's promoters, directors, key managers, employees and their relatives, as each disclosed them. Value is what the filer stated; the mode is shown where the shares moved off the market.
Pfizer stake sales and purchases
All 5 disclosures on record.
Mar 2025
- SoldLife Insurance Corporation of India2.02% of the company9,26,730 sharesholds 4.02% after18 Mar 2025 · filed under the 2% rule
Apr 2022
- SoldAditya Birla Sun Life Mutual Fund2.03% of the company9,30,573 sharesholds 4.97% after28 Apr 2022 · filed under the 2% rule · Open market
Mar 2021
- AcquiredLife Insurance Corporation of India0.11% of the company48,244 sharesholds 5.04% after9 Mar 2021 · filed under the 5% rule · Open Market
Nov 2018
- AcquiredAditya Birla Sun Life AMC Limited2.00% of the company9,16,069 sharesholds 7.00% after2 Nov 2018 · filed under the 2% rule · Open Market
Feb 2017
- AcquiredBirla sun Life Asset Management Company Ltd1,350 sharesholds 5.00% after10 Feb 2017 · filed under the 5% rule · Open Market
The 5% rule: an investor discloses on reaching 5% of the company. The 2% rule: a holder of 5% or more discloses each change of 2% or more, including one that takes it below 5%. A transfer exempt from an open offer, the offer to buy from every other shareholder that a large purchase otherwise brings, is disclosed too. Each line shows what its filing states, which can be a smaller change than its rule names.
Pfizer bulk deals
Last 12 months, since 30 Oct 2025: 3 bulk deals, ₹319 Cr bought and ₹200 Cr sold Bought and sold in deals. Each deal's shares times its price, added up for the buyers and apart for the sellers, so a block deal, which names both, counts on each side.Today's bulk and block deals, all companies
ValueValue of a deal. The shares traded times the deal's price.Per cent of the companyPer cent of the company. The shares traded as a percentage of all the company's shares in issue on the day of the deal.
Thursday 20 Aug 20261 firm · ₹131 Cr bought · ₹0 soldNet bought ₹131 Cr
- BoughtQUANT MUTUAL FUNDBought 2,67,864 at ₹4,899.970.59% of the company₹131 Cr
Friday 24 Apr 20262 firms · ₹188 Cr bought · ₹200 Cr soldNet sold ₹12 Cr
- SoldGOLDMAN SACHS FUNDS - GOLDMAN SACHS INDIA EQUITY PORTFOLIOSold 4,26,066 at ₹4,700.010.93% of the company₹200 Cr
- BoughtPRUDENTIAL ICICI MUTUAL FUND A/C DISCOVERY FUNDBought 4,00,000 at ₹4,700.000.87% of the company₹188 Cr
Wednesday 5 Dec 20072 firms · ₹14 Cr bought · ₹12 Cr soldNet bought ₹1.36 Cr
- BoughtRELIANCE CAPITAL TRUSTEE CO LTD AC RELIANCE TAX SAVER FUNDBought 2,00,215 at ₹685.00₹14 Cr
- SoldBIRLA SUNLIFE TRUSTEE CO PVT LTD AC INDIA EXCEL OFFSHORE FUNDSold 1,80,352 at ₹685.00₹12 Cr
Friday 13 Jul 20071 firm · ₹0 bought · ₹13 Cr soldNet sold ₹13 Cr
- SoldFIDELITY TRUSTEE CO PVT LTD FIDELITY EQUITY FUNDSold 1,57,247 at ₹803.00₹13 Cr
A bulk deal is one client trading more than half a per cent of the shares in a day; a block deal is a large trade in the exchange's separate block window, its buyer and its seller each on a line of their own. A firm that bought and sold the shares the same day is on one line, with its net. All 6 deals on record from 4 Jan 2004.